About xoma royalty - XOMA
XOMA Royalty Corp. operates as a biotech royalty aggregator, which engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets that provides right to future potential royalty and milestone payments. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.
XOMA At a Glance
XOMA Royalty Corp.
2200 Powell Street
Emeryville, California 94608
| Phone | 1-510-204-7200 | Revenue | 28.49M | |
| Industry | Pharmaceuticals: Major | Net Income | -13,821,000.00 | |
| Sector | Health Technology | 2024 Sales Growth | 498.718% | |
| Fiscal Year-end | 12 / 2025 | Employees | 13 | |
| View SEC Filings |
XOMA Valuation
| P/E Current | 33.427 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 10.794 |
| Price to Book Ratio | 3.837 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -8.054 |
| Enterprise Value to Sales | 11.241 |
| Total Debt to Enterprise Value | 0.372 |
XOMA Efficiency
| Revenue/Employee | 2,191,307.692 |
| Income Per Employee | -1,063,153.846 |
| Receivables Turnover | 1.674 |
| Total Asset Turnover | 0.124 |
XOMA Liquidity
| Current Ratio | 5.153 |
| Quick Ratio | 5.153 |
| Cash Ratio | 4.37 |
XOMA Profitability
| Gross Margin | 99.242 |
| Operating Margin | -140.331 |
| Pretax Margin | -68.379 |
| Net Margin | -48.517 |
| Return on Assets | -5.993 |
| Return on Equity | -16.199 |
| Return on Total Capital | -6.872 |
| Return on Invested Capital | -6.965 |
XOMA Capital Structure
| Total Debt to Total Equity | 145.504 |
| Total Debt to Total Capital | 59.267 |
| Total Debt to Total Assets | 52.519 |
| Long-Term Debt to Equity | 131.129 |
| Long-Term Debt to Total Capital | 53.38 |